This company has been marked as potentially delisted and may not be actively trading. Allakos (ALLK) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Allakos Short Interest DataAllakos (ALLK) has a short interest of 338,500 shares. This marks a -66.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1.25 million shares to cover all short positions.Current Short Interest338,500 sharesPrevious Short Interest1,020,000 sharesChange Vs. Previous Month-66.81%Dollar Volume Sold Short$110.32 thousandShort Interest Ratio0.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares90,377,000 sharesPercentage of Shares Shorted0.37%Today's Trading Volume0 sharesAverage Trading Volume1,250,862 sharesToday's Volume Vs. Average0% Short Selling Allakos? Sign up to receive the latest short interest report for Allakos and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALLK Short Interest Over TimeALLK Days to Cover Over TimeALLK Percentage of Float Shorted Over Time Allakos Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025338,500 shares $110.32 thousand -66.8%N/A0.3 $0.33 4/15/20251,020,000 shares $329.46 thousand -32.5%1.4%0.4 $0.32 3/31/20251,510,000 shares $343.68 thousand -9.6%2.0%0.6 $0.23 3/15/20251,670,000 shares $412.49 thousand -13.9%2.2%0.7 $0.25 2/28/20251,940,000 shares $542.81 thousand -18.8%2.6%0.9 $0.28 2/15/20252,390,000 shares $747.35 thousand -2.1%3.2%1.1 $0.31 1/31/20252,440,000 shares $586.09 thousand +167.0%N/A1.2 $0.24 1/15/2025914,000 shares $792.99 thousand +14.1%N/A0.6 $0.87 12/31/2024801,400 shares $969.69 thousand -4.9%N/A1.2 $1.21 12/15/2024842,800 shares $884.94 thousand -15.7%N/A1.3 $1.05 Get the Latest News and Ratings for ALLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter. 11/30/20241,000,000 shares $1.03 million -28.1%N/A1.5 $1.03 11/15/20241,390,000 shares $1.61 million -18.7%N/A2.1 $1.16 10/31/20241,710,000 shares $2.14 million +3.6%N/A2.8 $1.25 10/15/20241,650,000 shares $1.04 million -17.1%N/A3 $0.63 9/30/20241,990,000 shares $1.30 million +1.5%N/A5.8 $0.65 9/15/20241,960,000 shares $1.19 million +1.0%N/A3.6 $0.60 8/31/20241,940,000 shares $1.38 million -16.0%N/A3.5 $0.71 8/15/20242,310,000 shares $1.52 million -2.5%N/A4 $0.66 7/31/20242,370,000 shares $2.13 million -18.8%N/A3.9 $0.90 7/15/20242,920,000 shares $2.52 million -38.4%N/A4.7 $0.86 6/30/20244,740,000 shares $4.74 million -6.7%N/A7.7 $1.00 6/15/20245,080,000 shares $5.89 million +0.8%N/A10.7 $1.16 5/31/20245,040,000 shares $6.30 million -0.8%N/A10.4 $1.25 5/15/20245,080,000 shares $6.02 million -9.1%N/A9.6 $1.19 4/30/20245,590,000 shares $5.87 million -1.9%N/A9.4 $1.05 4/15/20245,700,000 shares $6.16 million +2.5%N/A7.3 $1.08 3/31/20245,560,000 shares $7.01 million -0.7%N/A3.9 $1.26 3/15/20245,600,000 shares $7.34 million +1.8%N/A3.7 $1.31 2/29/20245,500,000 shares $8.14 million +9.1%N/A3.4 $1.48 2/15/20245,040,000 shares $6.40 million +6.6%N/A3 $1.27 1/31/20244,730,000 shares $6.01 million +4.0%N/A2.9 $1.27 1/15/20244,550,000 shares $13.60 million -0.2%N/A3.1 $2.99 12/31/20234,560,000 shares $12.45 million +13.2%N/A5.3 $2.73 12/15/20234,030,000 shares $12.09 million +6.6%N/A4.2 $3.00 11/30/20233,780,000 shares $8.39 million +10.2%N/A3.7 $2.22 11/15/20233,430,000 shares $6.76 million -13.2%N/A3.6 $1.97 10/31/20233,950,000 shares $7.54 million +24.6%N/A3.7 $1.91 10/15/20233,170,000 shares $6.34 million -27.6%N/A2.8 $2.00 9/30/20234,380,000 shares $9.94 million -37.7%N/A4 $2.27 9/15/20237,030,000 shares $17.58 million +4.2%N/A7.1 $2.50Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 8/31/20236,750,000 shares $19.44 million +4.5%N/A7 $2.88 8/15/20236,460,000 shares $24.68 million -0.8%N/A6.5 $3.82 7/31/20236,510,000 shares $35.02 million +0.8%N/A6.5 $5.38 7/15/20236,460,000 shares $30.04 million -0.6%12.4%6.3 $4.65 6/30/20236,500,000 shares $28.34 million +28.7%12.5%6 $4.36 6/15/20235,050,000 shares $24.24 million +10.0%9.7%4.3 $4.80 5/31/20234,590,000 shares $22.86 million +6.5%8.9%4.3 $4.98 5/15/20234,310,000 shares $21.46 million -12.6%8.3%3.7 $4.98 4/30/20234,930,000 shares $20.95 million +12.8%9.5%4.6 $4.25 4/15/20234,370,000 shares $16.47 million +0.2%8.5%4.2 $3.77 3/31/20234,360,000 shares $19.40 million +17.2%9.3%4.2 $4.45 3/15/20233,720,000 shares $20.46 million +4.2%7.9%3.8 $5.50 2/28/20233,570,000 shares $21.24 million +39.5%7.6%3.4 $5.95 2/15/20232,560,000 shares $16.15 million -5.2%5.5%2.7 $6.31 1/31/20232,700,000 shares $20.06 million -3.9%5.8%2.6 $7.43 1/15/20232,810,000 shares $22.26 million -5.7%6.0%2.6 $7.92 12/30/20222,980,000 shares $25.09 million +20.2%6.3%2.9 $8.42 12/15/20222,480,000 shares $17.83 million +5.5%5.3%2 $7.19 11/30/20222,350,000 shares $19.39 million +11.4%5.0%1.5 $8.25 11/15/20222,110,000 shares $15.57 million -35.3%4.5%1 $7.38 10/31/20223,260,000 shares $19.01 million -0.6%N/A1.5 $5.83 10/15/20223,280,000 shares $19.45 million -20.8%N/A1.6 $5.93 9/30/20224,140,000 shares $25.34 million +18.3%N/A2 $6.12 9/15/20223,500,000 shares $18.31 million +54.2%7.3%1.8 $5.23 8/31/20222,270,000 shares $11.01 million +7.1%6.8%1.4 $4.85 8/15/20222,120,000 shares $7.95 million -11.3%6.3%2.3 $3.75 7/31/20222,390,000 shares $7.72 million -10.8%7.1%2.5 $3.23 7/15/20222,680,000 shares $9.67 million +14.0%8.0%2.6 $3.61 6/30/20222,350,000 shares $7.36 million -45.5%7.0%2.4 $3.13 6/15/20224,310,000 shares $12.07 million -17.8%12.9%4.3 $2.80 5/31/20225,240,000 shares $15.72 million -3.5%15.2%4.9 $3.00 5/15/20225,430,000 shares $17.59 million +6.7%15.7%5 $3.24 4/30/20225,090,000 shares $19.19 million +4.1%14.5%4.2 $3.77 4/15/20224,890,000 shares $26.31 million -3.7%14.0%3.4 $5.38 3/31/20225,080,000 shares $28.96 million +2.4%14.6%3 $5.70 3/15/20224,960,000 shares $25.20 million +8.1%14.2%1 $5.08 2/28/20224,590,000 shares $25.66 million +35.8%13.3%1 $5.59 2/15/20223,380,000 shares $23.19 million -5.9%9.8%0.7 $6.86 1/31/20223,590,000 shares $24.27 million +9.8%10.4%0.8 $6.76 1/15/20223,270,000 shares $24.98 million +12.4%9.5%0.8 $7.64 12/31/20212,910,000 shares $28.49 million +87.7%8.5%0.8 $9.79 12/15/20211,550,000 shares $130.98 million -8.3%4.5%0.5 $84.50 11/30/20211,690,000 shares $132.41 million -26.5%4.9%6.3 $78.35 11/15/20212,300,000 shares $190.56 million -4.6%6.7%9.9 $82.85 10/29/20212,410,000 shares $242.40 million -0.8%7.0%11.6 $100.58 10/15/20212,430,000 shares $261.18 million -15.6%7.1%12.2 $107.48 9/30/20212,880,000 shares $304.91 million -0.7%8.4%12.5 $105.87 9/15/20212,900,000 shares $313.87 million -11.9%8.5%11.4 $108.23 8/31/20213,290,000 shares $293.34 million -2.4%9.7%12.1 $89.16 8/13/20213,370,000 shares $277.65 million -13.1%9.9%12.4 $82.39Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 7/30/20213,880,000 shares $308.69 million +13.1%11.4%14.3 $79.56 7/15/20213,430,000 shares $271.79 million -10.4%10.1%13.4 $79.24 6/30/20213,830,000 shares $326.97 million +13.0%11.3%16.9 $85.37 6/15/20213,390,000 shares $311.20 million +3.4%10.0%17.1 $91.80 5/28/20213,280,000 shares $332.72 million +3.1%9.7%17.1 $101.44 5/14/20213,180,000 shares $311.45 million -0.6%9.4%15.6 $97.94 4/30/20213,200,000 shares $347.39 million +0.3%9.5%14.8 $108.56 4/15/20213,190,000 shares $343.21 million -0.6%9.5%13.3 $107.59 3/31/20213,210,000 shares $352.23 million +3.9%9.7%11.7 $109.73 3/15/20213,090,000 shares $383.13 million -1.6%9.3%9.8 $123.99 2/26/20213,140,000 shares $371.34 million +5.7%9.5%10 $118.26 2/12/20212,970,000 shares $416.93 million -5.7%9.1%9.7 $140.38 1/29/20213,150,000 shares $398.29 million -10.3%10.2%10.6 $126.44 1/15/20213,510,000 shares $451.21 million -15.8%11.3%10.8 $128.55 12/31/20204,170,000 shares $588.89 million -5.4%13.5%13.6 $141.22 12/15/20204,410,000 shares $532.86 million -3.7%15.6%16.6 $120.83 11/30/20204,580,000 shares $479.57 million -0.2%16.3%19.1 $104.71 11/15/20204,590,000 shares $462.30 million -11.1%16.1%20.7 $100.72 10/30/20205,160,000 shares $458.36 million -14.3%19.1%24.4 $88.83 10/15/20206,020,000 shares $493.58 million -5.2%23.9%34.5 $81.99 9/30/20206,350,000 shares $517.21 million -3.4%25.3%33.1 $81.45 9/15/20206,570,000 shares $542.62 million +1.1%26.1%30.3 $82.59 8/31/20206,500,000 shares $582.27 million -1.4%25.8%27.1 $89.58 ALLK Short Interest - Frequently Asked Questions What is Allakos' current short interest? Short interest is the volume of Allakos shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 338,500 shares of ALLK short. Learn More on Allakos' current short interest. Is Allakos' short interest increasing or decreasing? Allakos saw a decline in short interest in April. As of April 30th, there was short interest totaling 338,500 shares, a decline of 66.8% from the previous total of 1,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Allakos' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Allakos: Coya Therapeutics, Inc. (1.63%), IO Biotech, Inc. (1.76%), Equillium, Inc. (2.43%), Adagene Inc. Sponsored ADR (0.16%), Biomea Fusion, Inc. (15.00%), Anebulo Pharmaceuticals, Inc. (1.77%), MacroGenics, Inc. (6.97%), Cassava Sciences, Inc. (13.40%), TScan Therapeutics, Inc. (3.75%), Alto Neuroscience, Inc. (10.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Corporation ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Allakos stock? Short selling ALLK is an investing strategy that aims to generate trading profit from Allakos as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allakos? A short squeeze for Allakos occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLK, which in turn drives the price of the stock up even further. How often is Allakos' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLK, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Coya Therapeutics Short Squeeze IO Biotech Short Squeeze Equillium Short Squeeze Adagene Short Squeeze Biomea Fusion Short Squeeze Anebulo Pharmaceuticals Short Squeeze MacroGenics Short Squeeze Cassava Sciences Short Squeeze TScan Therapeutics Short Squeeze Alto Neuroscience Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALLK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allakos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allakos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access